CIRM Funding Commitments
CIRM carefully tracks funds spent on each round of funding. The table below shows the following values for each round of funding:
ICOC approved funding: The funding level approved by the Governing Board. This is the value that is originally reported in the press release and in the award summary.
Award value: The current total authorized funding for the award issued by CIRM, reflecting budget review by CIRM and any adjustments made during the course of the award.
Disbursed funds: The actual funds disbursed to date for each round of funding. Many awards span multiple years, and funds are given out throughout period of the award. This amount gets reduced if award funds are returned to CIRM.
Find Out More:
Stem Cell FAQ
Stem Cell Videos
Search CIRM Grants
Rounds of Funding
| Program | Total Awards | ICOC Approved Funding | Award value | Disbursed funds |
|---|---|---|---|---|
Late Stage Preclinical ProjectsMost Recent Approval:
September 26, 2024
|
49 | $226,421,029.00 | $216,548,125.23 | $160,376,181.23 |
ReMIND – Discovery Stage ReMINDMost Recent Approval:
August 30, 2024
|
5 | $67,524,203.00 | $67,524,203.00 | $0.00 |
Clinical Trial Stage ProjectsMost Recent Approval:
July 25, 2024
|
92 | $903,214,823.00 | $778,555,851.59 | $540,720,583.37 |
Conference IIMost Recent Approval:
July 8, 2024
|
84 | $2,745,460.00 | $2,643,303.94 | $2,348,663.65 |
Diagnostic Translational Research ProjectsMost Recent Approval:
May 30, 2024
|
3 | $3,256,981.00 | $3,242,566.41 | $1,707,191.41 |
Therapeutic Translational Research ProjectsMost Recent Approval:
May 30, 2024
|
81 | $357,086,259.00 | $332,936,161.80 | $223,202,467.80 |
Tool Translational Research ProjectsMost Recent Approval:
May 30, 2024
|
7 | $8,271,739.00 | $8,009,895.00 | $4,499,382.00 |
Foundation – Discovery Stage Research ProjectsMost Recent Approval:
March 28, 2024
|
39 | $58,117,300.00 | $55,025,047.00 | $22,208,592.00 |
Conference – Manage The SPARK Annual MeetingMost Recent Approval:
January 16, 2024
|
7 | $480,049.00 | $424,073.58 | $396,573.58 |
Conference – 2024 CIRM Trainee Network ConferenceMost Recent Approval:
November 29, 2023
|
1 | $400,000.00 | $400,000.00 | $300,000.00 |
Manufacturing Network GrantMost Recent Approval:
September 28, 2023
|
9 | $17,717,436.00 | $17,541,593.00 | $8,520,000.00 |
Quest – Discovery Stage Research ProjectsMost Recent Approval:
September 28, 2023
|
144 | $216,580,468.00 | $207,875,013.71 | $175,821,453.71 |
Conference – The Alpha Stem Cell Clinic Annual SymposiumMost Recent Approval:
July 24, 2023
|
2 | $119,975.00 | $56,250.19 | $56,250.19 |
Alpha Stem Cell Clinics Network ExpansionMost Recent Approval:
October 27, 2022
|
12 | $89,215,209.00 | $86,329,981.40 | $42,981,878.40 |
COMPASS Training GrantMost Recent Approval:
August 30, 2022
|
16 | $46,076,430.00 | $45,759,509.82 | $12,850,952.82 |
Medical Device Translational Research ProjectsMost Recent Approval:
April 19, 2022
|
1 | $3,112,567.00 | $3,082,579.00 | $2,750,000.00 |
SPARKMost Recent Approval:
December 14, 2021
|
18 | $7,645,212.00 | $7,277,888.09 | $4,723,464.09 |
Conference – Manage The Bridges Annual MeetingMost Recent Approval:
December 13, 2021
|
4 | $965,000.00 | $707,548.31 | $707,548.31 |
Research Training GrantMost Recent Approval:
September 23, 2021
|
18 | $93,127,509.00 | $93,118,807.00 | $41,236,752.00 |
BridgesMost Recent Approval:
July 20, 2021
|
29 | $91,559,405.00 | $87,213,476.84 | $64,423,660.84 |
Cure Sickle Cell Initiative Clinical Trial Stage ProjectsMost Recent Approval:
July 20, 2021
|
3 | $18,722,988.00 | $17,322,988.00 | $12,400,000.00 |
Progression Award – Discovery Stage Research ProjectsMost Recent Approval:
November 10, 2020
|
8 | $1,718,937.00 | $1,666,728.00 | $1,666,728.00 |
Discovery Research ProjectsMost Recent Approval:
July 24, 2020
|
12 | $2,299,878.00 | $2,214,780.39 | $2,214,780.39 |
Conference – The 2020 Grantee MeetingMost Recent Approval:
July 22, 2020
|
1 | $207,794.00 | $176,762.04 | $176,762.04 |
Discovery Research ProjectsMost Recent Approval:
July 10, 2020
|
1 | $150,000.00 | $150,000.00 | $150,000.00 |
Clinical Trial Stage ProjectsMost Recent Approval:
June 26, 2020
|
3 | $2,499,999.00 | $2,016,048.00 | $1,991,048.00 |
Therapeutic Translational Research ProjectsMost Recent Approval:
June 12, 2020
|
1 | $349,999.00 | $349,999.00 | $349,999.00 |
Conference – The 2019 Alpha Stem Cell Clinic Annual SymposiumMost Recent Approval:
October 17, 2018
|
1 | $60,000.00 | $60,000.00 | $60,000.00 |
Conference – The 2018 Alpha Stem Cell Clinic Annual SymposiumMost Recent Approval:
December 27, 2017
|
1 | $60,000.00 | $60,000.00 | $60,000.00 |
Inception – Discovery Stage Research ProjectsMost Recent Approval:
November 30, 2017
|
39 | $8,591,003.00 | $8,364,091.97 | $8,364,091.97 |
Conference – Manage a Symposium on Pluripotent Stem Cell ManufacturingMost Recent Approval:
August 21, 2017
|
1 | $100,000.00 | $100,000.00 | $100,000.00 |
Conference – The 2017 Alpha Stem Cell Clinic Annual SymposiumMost Recent Approval:
January 30, 2017
|
1 | $80,000.00 | $79,287.35 | $79,287.35 |
Translating CenterMost Recent Approval:
October 19, 2016
|
1 | $15,000,000.00 | $15,000,000.00 | $15,000,000.00 |
Accelerating CenterMost Recent Approval:
June 15, 2016
|
1 | $15,000,000.00 | $11,772,453.00 | $11,772,453.00 |
Conference – Lung Regenerative Medicine WorkshopMost Recent Approval:
May 20, 2016
|
1 | $50,000.00 | $44,548.00 | $44,548.00 |
Conference – Manage The 2016 Bridges And SPARK Annual MeetingsMost Recent Approval:
February 23, 2016
|
1 | $205,747.00 | $205,388.00 | $205,388.00 |
Conference – The 2016 Alpha Stem Cell Clinic Annual SymposiumMost Recent Approval:
January 21, 2016
|
1 | $37,778.00 | $37,778.00 | $37,778.00 |
Preclinical Development AwardsMost Recent Approval:
March 26, 2015
|
7 | $25,205,737.00 | $24,260,589.00 | $24,260,589.00 |
ConferenceMost Recent Approval:
February 9, 2015
|
81 | $1,704,766.00 | $1,640,318.25 | $1,640,318.25 |
Tools and Technologies IIIMost Recent Approval:
January 29, 2015
|
22 | $31,067,229.00 | $29,579,837.86 | $29,579,837.86 |
Alpha Stem Cell ClinicsMost Recent Approval:
October 23, 2014
|
3 | $26,039,137.00 | $25,775,667.97 | $25,775,667.97 |
Accelerated Development Pathway IMost Recent Approval:
September 10, 2014
|
1 | $16,603,160.00 | $8,783,852.00 | $8,783,852.00 |
Research LeadershipMost Recent Approval:
May 29, 2014
|
14 | $81,018,340.00 | $46,207,977.63 | $46,207,977.63 |
Strategic Partnership III Track AMost Recent Approval:
May 29, 2014
|
2 | $19,906,756.00 | $19,906,756.00 | $19,906,756.00 |
Basic Biology VMost Recent Approval:
January 29, 2014
|
28 | $26,985,290.00 | $26,304,499.54 | $26,304,499.54 |
Genomics Centers of Excellence Awards (R)Most Recent Approval:
January 29, 2014
|
3 | $40,000,001.00 | $39,988,631.88 | $39,988,631.88 |
Disease Team Therapy Development IIIMost Recent Approval:
December 12, 2013
|
6 | $61,128,419.00 | $49,035,312.54 | $48,785,312.54 |
Early Translational IVMost Recent Approval:
August 28, 2013
|
14 | $40,620,811.00 | $38,460,588.51 | $38,460,588.51 |
Strategic Partnership IIMost Recent Approval:
May 23, 2013
|
1 | $6,374,150.00 | $2,760,540.00 | $2,760,540.00 |
hiPSC DerivationMost Recent Approval:
March 19, 2013
|
1 | $16,000,000.00 | $16,000,000.00 | $16,000,000.00 |
hPSC RepositoryMost Recent Approval:
March 19, 2013
|
1 | $9,999,834.00 | $9,942,175.00 | $9,942,175.00 |
Tissue Collection for Disease ModelingMost Recent Approval:
March 19, 2013
|
7 | $6,317,801.00 | $5,933,552.02 | $5,933,552.02 |
New Faculty Physician ScientistMost Recent Approval:
December 12, 2012
|
15 | $36,682,565.00 | $34,090,594.62 | $34,090,594.62 |
Strategic Partnership IMost Recent Approval:
October 25, 2012
|
2 | $19,438,405.00 | $9,475,070.00 | $9,475,070.00 |
Basic Biology IVMost Recent Approval:
September 6, 2012
|
28 | $38,042,886.00 | $35,369,713.60 | $35,369,713.60 |
Disease Team Therapy Development – ResearchMost Recent Approval:
July 27, 2012
|
12 | $208,065,406.00 | $139,696,538.68 | $139,696,538.68 |
Early Translational from Disease Team ConversionMost Recent Approval:
July 26, 2012
|
3 | $11,644,754.00 | $7,468,299.00 | $7,468,299.00 |
Early Translational IIIMost Recent Approval:
May 24, 2012
|
21 | $69,354,071.00 | $63,935,513.86 | $63,935,513.86 |
iPSC Consortia AwardMost Recent Approval:
April 1, 2012
|
1 | $300,000.00 | $300,000.00 | $300,000.00 |
Creativity AwardsMost Recent Approval:
March 21, 2012
|
9 | $2,316,580.00 | $1,963,544.73 | $1,963,544.73 |
Disease Team Therapy Planning IMost Recent Approval:
August 25, 2011
|
19 | $1,828,766.00 | $1,501,520.13 | $1,501,520.13 |
Patent Assistance Fund AwardsMost Recent Approval:
June 11, 2011
|
8 | $1,500,000.00 | $382,230.81 | $382,230.81 |
Basic Biology IIIMost Recent Approval:
May 4, 2011
|
27 | $37,767,073.00 | $35,179,294.96 | $35,179,294.96 |
Targeted Clinical DevelopmentMost Recent Approval:
May 4, 2011
|
1 | $24,846,856.00 | $0.00 | $-53,399.33 |
Tools and Technologies IIMost Recent Approval:
January 27, 2011
|
20 | $34,675,392.00 | $31,907,983.97 | $31,907,983.97 |
Early Translational IIMost Recent Approval:
October 21, 2010
|
24 | $74,117,136.00 | $63,335,498.42 | $63,335,498.42 |
Basic Biology IIMost Recent Approval:
April 29, 2010
|
16 | $22,800,731.00 | $20,847,711.37 | $20,847,711.37 |
Transplantation ImmunologyMost Recent Approval:
April 29, 2010
|
20 | $25,112,351.00 | $23,966,409.01 | $23,966,409.01 |
Disease Team Research IMost Recent Approval:
October 28, 2009
|
15 | $224,006,191.00 | $182,842,803.66 | $159,672,906.87 |
Basic Biology IMost Recent Approval:
August 20, 2009
|
12 | $16,409,447.00 | $15,156,451.07 | $15,156,451.07 |
Early Translational IMost Recent Approval:
April 29, 2009
|
16 | $74,419,090.00 | $71,265,763.14 | $71,265,763.14 |
BridgesMost Recent Approval:
January 30, 2009
|
16 | $59,503,408.00 | $54,849,836.90 | $54,849,836.90 |
Research Training IIMost Recent Approval:
January 30, 2009
|
17 | $91,957,136.00 | $83,448,124.61 | $83,448,124.61 |
Tools and Technologies IMost Recent Approval:
December 10, 2008
|
23 | $19,804,588.00 | $19,147,804.89 | $19,147,804.89 |
New Faculty IIMost Recent Approval:
August 13, 2008
|
24 | $59,513,844.00 | $57,684,225.33 | $57,684,225.33 |
Disease Team PlanningMost Recent Approval:
June 27, 2008
|
22 | $1,120,368.00 | $739,156.49 | $739,156.49 |
New Cell LinesMost Recent Approval:
June 27, 2008
|
18 | $24,900,729.00 | $24,252,205.19 | $24,252,205.19 |
Major FacilitiesMost Recent Approval:
May 7, 2008
|
12 | $270,946,930.00 | $270,756,210.17 | $270,756,210.17 |
New Faculty IMost Recent Approval:
January 17, 2008
|
26 | $54,551,401.00 | $49,664,222.60 | $49,664,222.60 |
Shared LabsMost Recent Approval:
June 5, 2007
|
34 | $71,015,911.00 | $69,250,744.48 | $69,250,744.48 |
Comprehensive GrantMost Recent Approval:
March 16, 2007
|
29 | $72,031,576.00 | $66,383,182.05 | $66,383,182.05 |
SEED GrantMost Recent Approval:
February 16, 2007
|
74 | $45,329,918.00 | $41,436,156.33 | $41,436,156.33 |
Training Grant I-1Most Recent Approval:
September 9, 2005
|
8 | $25,198,795.00 | $21,432,455.61 | $21,432,455.61 |
Training Grant I-2Most Recent Approval:
September 9, 2005
|
5 | $9,655,586.00 | $8,266,419.58 | $8,266,419.58 |
Training Grant I-3Most Recent Approval:
September 9, 2005
|
3 | $4,057,871.00 | $3,370,368.71 | $3,370,368.71 |
| Total: 1469 | Total: $4,400,658,369.00 | Total: $3,927,839,078.83 | Total: $3,194,977,515.20 |